The PCBP1 gene (Poly(rC)-Binding Protein 1), also known as HNRNP E1 or hnRNP-E1, encodes a critical RNA-binding protein involved in post-transcriptional gene regulation. PCBP1 contains three KH (hnRNP K homology) domains that facilitate sequence-specific RNA binding, enabling participation in mRNA stability, translation regulation, RNA processing, and viral replication. [1]
Recent research has revealed that PCBP1 plays significant roles in neurodegenerative disease pathogenesis, particularly through its involvement in alpha-synuclein regulation, oxidative stress response, iron homeostasis, and DNA damage response. [2] The protein is expressed ubiquitously but shows enriched expression in brain regions affected by neurodegenerative processes, including the substantia nigra, hippocampus, and cortex.
| Attribute | Value | Source |
|---|---|---|
| Gene Symbol | PCBP1 | [2:1] |
| Full Name | Poly(rC) Binding Protein 1 | [1:1] |
| Chromosomal Location | 9p21.1 | NCBI Gene Database |
| Aliases | HNRNP E1, hnRNP-E1, αCP1 | [1:2] |
| NCBI Gene ID | 5099 | NCBI |
| UniProt ID | Q15365 | UniProt |
| Ensembl ID | ENSG00000131469 | Ensembl |
| OMIM | 604213 | OMIM |
| Molecular Weight | ~38 kDa | [1:3] |
| Protein Length | 371 amino acids | UniProt |
PCBP1 belongs to the heterogeneous nuclear ribonucleoprotein (hnRNP) family and contains three highly conserved KH (hnRNP K Homology) domains. Each KH domain consists of approximately 50-60 amino acids forming a β-α-α-β-β-α fold that recognizes single-stranded RNA and DNA sequences. The KH domains are connected by variable spacer sequences, allowing PCBP1 to recognize diverse nucleic acid targets.
The three KH domains (KH1, KH2, KH3) exhibit different RNA binding affinities and specificities:
This modular architecture enables PCBP1 to simultaneously bind multiple RNA targets and regulate complex post-transcriptional networks. [1:4]
PCBP1 participates in multiple layers of post-transcriptional gene regulation:
PCBP1 binds to AU-rich elements (AREs) and C-rich sequences in the 3' untranslated regions (3'UTRs) of target mRNAs. These interactions can either stabilize or destabilize mRNA transcripts depending on the context and associated proteins. Through this mechanism, PCBP1 regulates the expression of transcripts encoding:
PCBP1 can both promote and inhibit translation initiation through multiple mechanisms:
The dual functionality of PCBP1 as both a translational activator and repressor allows fine-tuned protein expression in response to cellular conditions. [1:5]
As an hnRNP protein, PCBP1 influences splice site selection and alternative splicing patterns. PCBP1 binding to exonic or intronic regulatory sequences can:
Dysregulation of PCBP1-mediated splicing contributes to neuronal dysfunction in neurodegenerative diseases.
Beyond its canonical RNA-binding functions, PCBP1 exhibits iron regulatory protein (IRP) activity. PCBP1 can bind to iron-responsive elements (IREs) in the 5' or 3' UTRs of iron metabolism genes, regulating their translation or stability in response to cellular iron levels. [3]
This iron regulatory function connects PCBP1 to:
Dysregulated iron homeostasis is a hallmark of multiple neurodegenerative disorders, making PCBP1's iron regulatory role particularly relevant to disease mechanisms.
PCBP1 is expressed ubiquitously across human tissues, with highest expression in:
Within the central nervous system, PCBP1 shows neuronal expression with enrichment in:
PCBP1 expression in dopaminergic neurons of the substantia nigra pars compacta is particularly relevant to Parkinson's disease pathogenesis, as these neurons are selectively vulnerable in PD.
PCBP1 localizes to both the nucleus and cytoplasm:
The shuttling of PCBP1 between nuclear and cytoplasmic compartments is regulated by cellular signals and stress conditions.
PCBP1 has emerged as a significant regulator in Parkinson's disease pathogenesis through multiple mechanisms:
The most prominent connection between PCBP1 and PD is its regulation of alpha-synuclein (SNCA) expression. PCBP1 binds to the SNCA mRNA 3'UTR and regulates its translation. [4] Studies have shown that:
The regulation of alpha-synuclein by PCBP1 represents a potential therapeutic target for modulating the key protein implicated in PD pathogenesis.
PD is characterized by oxidative stress in dopaminergic neurons. PCBP1 plays protective roles against oxidative damage:
[5] demonstrated that PCBP1 attenuates MPP+-induced neuronal injury through modulation of oxidative stress and apoptosis pathways.
PCBP1 influences mitochondrial dynamics and function through:
Dysregulated PCBP1 contributes to mitochondrial dysfunction, a central feature of PD pathogenesis.
PCBP1 involvement in Alzheimer's disease has been demonstrated through several lines of evidence:
Although direct regulation of amyloid precursor protein (APP) or amyloid-beta (Aβ) by PCBP1 has not been established, the protein influences pathways relevant to AD pathogenesis:
[6] identified PCBP1 genetic variants associated with altered Alzheimer's disease risk in genome-wide association studies.
PCBP1 may influence tau phosphorylation and aggregation:
PCBP1's role in synaptic local protein synthesis is relevant to synaptic dysfunction in AD:
ALS is characterized by accumulation of TDP-43 (TAR DNA-binding protein 43) in motor neurons. PCBP1 interacts with TDP-43 and regulates shared target RNAs. [7]
Both PCBP1 and TDP-43 are components of stress granules, membrane-less organelles that form in response to cellular stress. In ALS:
PCBP1 expression is altered in Huntington's disease, and the protein may regulate:
PCBP1 dysregulation has been observed in MSA, particularly in oligodendrocytes where alpha-synuclein aggregates form.
PCBP1 plays important roles in autophagy regulation, a cellular process critical for clearing misfolded proteins and damaged organelles. [8]
PCBP1 integrates with the broader proteostasis network:
PCBP1 contributes to DNA repair mechanisms:
PCBP1 regulates expression of DNA glycosylases and repair enzymes involved in base excision repair, the primary pathway for repairing oxidative DNA damage.
PCBP1 influences expression of repair proteins involved in homologous recombination and non-homologous end joining.
Accumulated DNA damage is a feature of aging and neurodegenerative diseases. PCBP1's role in DNA repair connects to:
PCBP1 represents a potential therapeutic target for neurodegenerative diseases:
Development of small molecules that:
ASOs targeting PCBP1 mRNA to:
Viral vector-mediated PCBP1 delivery to:
PCBP1 knockout mice exhibit:
Neuron-specific PCBP1 deletion:
PCBP1 overexpression models:
PCBP1 has potential as a biomarker for neurodegenerative diseases:
Makeyev AV, et al. The PCBP family of RNA-binding proteins. RNA Biol. 2011. 2011. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Singh A, et al. PCBP1 regulates alpha-synuclein expression. J Mol Neurosci. 2019. 2019. ↩︎ ↩︎
Kim J, et al. PCBP1-mediated iron homeostasis in neurodegeneration. Nat Neurosci. 2017. 2017. ↩︎
Wang E, et al. PCBP1 suppresses translation of alpha-synuclein mRNA. J Neurosci. 2018. 2018. ↩︎
Choi J, et al. PCBP1 regulates oxidative stress and apoptosis in PD. Cell Death Dis. 2019. 2019. ↩︎
Park H, et al. PCBP1 genetic variants and risk for Alzheimer's disease. J Alzheimers Dis. 2018. 2018. ↩︎
Liu X, et al. PCBP1 and TDP-43 interaction in ALS pathogenesis. Acta Neuropathol. 2021. 2021. ↩︎
Chen W, et al. PCBP1 regulates autophagy in neurodegenerative diseases. Autophagy. 2020. 2020. ↩︎